Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment

Objectives

To evaluate the prognostic and predictive value of treatment efficacy based on changes in circulating tumor cell (CTC) counts during treatment.

References

Official title:

Stay informed. Subscribe to our newsletter.

Follow ScreenCell on

linkedin logo